US 10093698
Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same
granted A61KA61K38/00A61K38/08
Quick answer
US patent 10093698 (Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same) held by CAREGEN CO., LTD. expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K38/08